Implanted Microchip Might Be Future of Drug
THURSDAY, Feb. 16 (HealthDay News) -- Remote controls may not be
for just appliances anymore. In a new small study, women with
severe osteoporosis were implanted with a microchip that releases
bone-building drugs at the push of a button, a delivery method that
could someday become common for various health conditions.
Roughly 1.5-by-2.5 inches in size, the microchip significantly
improved patient compliance with a drug regimen that normally
requires painful daily self-injections, study authors said. The
clinical trial, conducted on seven osteoporosis patients in
Denmark, was the first to test a wirelessly controlled microchip in
"It frees patients from the burden of managing their disease on a daily basis," said Robert Farra, co-author of the study and president and chief operating officer of MicroCHIPS Inc., the Waltham, Mass., company that funded and supervised the trial. "I think there will be a class of drugs [for other conditions] that will be very suitable to use the chip for . . . we were very pleased with the results."
The study is published Feb. 16 in the journal
Science Translational Medicine, coinciding with its presentation at the American Association for the Advancement of Science annual meeting in Vancouver, Canada.
Along with researchers from MIT, Harvard Medical School and
other companies and institutions, Farra implanted the microchip
just under the skin near the waistline of the seven women, who
ranged from ages 65 to 70 and had been using pre-filled injection
pens containing teriparatide (brand name Forteo) for their severe
osteoporosis, a bone-thinning disease.
Although a fibrous membrane grew around the device, which was
expected, the microchip delivered the drug as effectively as daily
injections, the study said. Blood tests done after the 12-month
study period indicated rates of bone formation similar to when the
women self-injected the drug.
Because daily injections can be psychologically and physically
challenging, Farra said, only 25 percent of patients on
teriparatide actually finish a typical 24-month regimen. But with
the implant -- which delivered 20 timed doses controlled by doctors
-- the compliance rate rose to 100 percent.
About 50,000 Americans take the drug each year at a cost of
$10,000 to $12,000, which would be comparable to the cost of the
microchip and the minor surgery to embed it, he said. The microchip
can be implanted under local anesthesia in a doctor's office.
"It not only should offer a better quality of life, we should see improved outcomes because of the compliance boost," Farra said, adding that his company is developing a model that will deliver a year's worth of doses. He said he hopes it is approved by the U.S. Food and Drug Administration and on the market within four years.
Dr. Robert Recker, director of the Osteoporosis Research Center
at Creighton University in Omaha, Neb., said he was skeptical that
the microchip could keep the Forteo stable at body temperature
since the drug is normally refrigerated when contained in injection
However, Farra said that researchers had modified the drug to
make this possible, an effort made easier because each dose was
also sealed in tiny air- and moisture-proof compartments in the
The reservoirs pop open on a pre-programmed schedule or via a
wireless signal, which can be sent from a doctor's computer or
smartphone, Farra said.
"I do not see how this can be done with [a] reservoir, either above or below the skin surface," Recker said. "I think the claim must be corroborated with more studies. They must explain how they preserve the drug at body temperature."
The University of New Hampshire has more about
human microchip implantation.
Copyright © 2012
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.